Protocol Layering in Computer Networks: A Comparative Survey on OSI and TCP/IP Applications, Security Vulnerabilities, and Cross-Layer Directions
AlQalam Journal of Medical and Applied Sciences · 30.06.2026
DOI: 10.54361/ajmas.269646 ↗Kurz gefasst
Studienprotokoll in der Zeitschrift AlQalam Journal of Medical and Applied Sciences, online erschienen am 29.06.2026. Verfasst von Nuredin Ahmed.
Abstract (Originalsprache)
This paper presents a systematic literature review (SLR) of protocol layering architectures, comparing the OSI seven-layer model with the TCP/IP four-layer suite based on literature published between 2022 and 2026. The review finds that strict protocol layering creates systemic vulnerabilities. Informational isolation between layers enables DHCP starvation attacks, where servers accept spoofed requests due to a lack of link-layer authentication. Additionally, HTTP/TCP performance suffers when transport protocols misinterpret reconfiguration events as congestion. In response, the study examines Cross-Layer Design (CLD) as an alternative paradigm. CLD enables controlled information sharing across non-adjacent layers but introduces trade-offs, including loss of modularity and increased complexity.
Zitieren
APA
Ahmed, N. (2026). Protocol Layering in Computer Networks: A Comparative Survey on OSI and TCP/IP Applications, Security Vulnerabilities, and Cross-Layer Directions. AlQalam Journal of Medical and Applied Sciences. https://doi.org/10.54361/ajmas.269646
Vancouver
Ahmed N. Protocol Layering in Computer Networks: A Comparative Survey on OSI and TCP/IP Applications, Security Vulnerabilities, and Cross-Layer Directions. AlQalam Journal of Medical and Applied Sciences. 2026. doi:10.54361/ajmas.269646
BibTeX
@article{Ahmed2026,
author = {Ahmed, Nuredin},
title = {Protocol Layering in Computer Networks: A Comparative Survey on OSI and TCP/IP Applications, Security Vulnerabilities, and Cross-Layer Directions},
journal = {AlQalam Journal of Medical and Applied Sciences},
year = {2026},
doi = {10.54361/ajmas.269646}
}
EUVIMED